{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:50:00Z","timestamp":1787748600051,"version":"build-2784847793"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02904-6","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T08:07:17Z","timestamp":1752826037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Organizing pneumonia in ALK+ non-small cell lung cancer treated with ceritinib: a case report"],"prefix":"10.1007","volume":"16","author":[{"given":"Xiao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"2904_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"Cancer J Clin"},{"key":"2904_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.13416","author":"K Koshikawa","year":"2020","unstructured":"Koshikawa K, Terada J, Abe M, Iwasawa S, Sakayori M, Yoshioka K, et al. Clinical characteristics and risk factors of drug-induced lung injury by ALK tyrosine kinase inhibitors: a single center retrospective analysis. Thoracic Cancer. 2020. https:\/\/doi.org\/10.1111\/1759-7714.13416.","journal-title":"Thoracic Cancer"},{"key":"2904_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214886","author":"BJ Solomon","year":"2013","unstructured":"Solomon BJ, Mok T, Kim D-W, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013. https:\/\/doi.org\/10.1056\/NEJMoa1214886.","journal-title":"N Engl J Med"},{"key":"2904_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3405-3","author":"Q Zhu","year":"2017","unstructured":"Zhu Q, Hu H, Weng DS, et al. Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC. BMC Cancer. 2017. https:\/\/doi.org\/10.1186\/s12885-017-3405-3.","journal-title":"BMC Cancer"},{"key":"2904_CR5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0840","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Gandhi L, Gadgeel S, et al. The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer. Cancer Discov. 2014. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0840.","journal-title":"Cancer Discov"},{"key":"2904_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70362-6","author":"SM Gadgeel","year":"2014","unstructured":"Gadgeel SM, Gandhi L, Riely GJ, et al. Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1\/2 study. Lancet Oncol. 2014. https:\/\/doi.org\/10.1016\/S1470-2045(14)70362-6.","journal-title":"Lancet Oncol"},{"key":"2904_CR7","doi-asserted-by":"publisher","DOI":"10.2165\/11207680-000000000-00000","author":"MP Curran","year":"2012","unstructured":"Curran MP. Crizotinib. Drugs. 2012. https:\/\/doi.org\/10.2165\/11207680-000000000-00000.","journal-title":"Drugs"},{"key":"2904_CR8","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-22-857","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Shi Y, Liu Y, et al. Efficacy and safety of alectinib in ALK-positive non-small cell lung cancer and blood markers for prognosis and efficacy: a retrospective cohort study. Transl Lung Cancer Res. 2022. https:\/\/doi.org\/10.21037\/tlcr-22-857.","journal-title":"Transl Lung Cancer Res"},{"key":"2904_CR9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al. An official American thoracic society\/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2904_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014553619","author":"MR Cooper","year":"2015","unstructured":"Cooper MR, Chim H, Chan H, Durand C. Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancer. Ann Pharmacother. 2015. https:\/\/doi.org\/10.1177\/1060028014553619.","journal-title":"Ann Pharmacother"},{"key":"2904_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00733-x","author":"W Choi","year":"2020","unstructured":"Choi W, Lim H-J, Park SY, et al. Ceritinib-induced organizing pneumonia in lung cancer: a retrospective analysis. Target Oncol. 2020. https:\/\/doi.org\/10.1007\/s11523-020-00733-x.","journal-title":"Target Oncol"},{"key":"2904_CR12","doi-asserted-by":"publisher","DOI":"10.21037\/apm-19-420","author":"X Gou","year":"2021","unstructured":"Gou X, Yuan C, Bai Y, Shi L, Xing S, Ma H. Pneumonia caused by crizotinib: case report and review of literature. Ann Palliative Med. 2021. https:\/\/doi.org\/10.21037\/apm-19-420.","journal-title":"Ann Palliative Med"}],"updated-by":[{"DOI":"10.1007\/s12672-026-04810-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000}}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02904-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T01:47:11Z","timestamp":1787708831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02904-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02904-6","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12672-026-04810-x","URL":"https:\/\/doi.org\/10.1007\/s12672-026-04810-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies involving human participants were reviewed and approved by the Ethical Committee of the First Affiliated Hospital of Wenzhou Medical University. All the experimental protocol for involving human data was in accordance with the guidelines of our institutional Declaration of Helsinki in the manuscript, and written informed consent from the study patient was obtained. Informed consent to participate in the study was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent to publish this case report and accompanying clinical data\/imaging was obtained from the patient.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1363"}}